Printer Friendly

TOPOX REPORTS RESULTS FOR FISCAL YEAR ENDED MARCH 31, 1992

 TOPOX REPORTS RESULTS FOR FISCAL YEAR ENDED MARCH 31, 1992
 CHADDS FORD, Pa., July 30 /PRNewswire/ -- Topox, Inc. (AMEX: TPO.EC) today reported revenues of $122,747 and a net loss of $675,319 for the fourth quarter ended March 31, 1992.
 This compares to revenues of $84,617 and a net loss of $34,193 for the same quarter in 1991. For the year ended March 31, 1992, revenues were reported at $530,283 and a net loss of $954,437 or $.06 per share. This compares to revenues of $175,729 and a net loss of $22,851 for the same period 1991.
 The 1992 fiscal year was a time of dramatic change for Topox. Sophisticated ultrasound technology was acquired and new management was installed. The increased revenues in 1992 were a result of more rental capacity and greater marketing efforts. The increase in expenses was attributed to additional research and development, clinical studies, new marketing programs and increased general and administrative costs.
 During the fiscal year 1992, the liquidity of the company increased significantly. Current assets increased 662 percent from $178,596 to $1,361,086 and total assets increased 1,105 percent from $361,091 to $4,350,265. Shareholders' equity increased 1,006 percent from $313,043 to $3,462,173. The primary reasons for the company's increased liquidity and shareholder equity positions was a significant equity investment made during the fiscal year and the acquisition of the Supra Scanner technology, patents and licenses.
 Topox, Inc. develops and markets proprietary medical products which are used in the diagnosis, monitoring and ongoing treatment of wounds, ulcerations, burns and other skin disorders including skin cancer and melanoma.
 For more information, please contact George Stasen, COO/EVP, at 800-38-TOPOX.
 TOPOX, INC.
 Balance Sheet
 At March 31 1992 1991
 Assets:
 Current assets:
 Cash and cash equivalents $1,106,600 $32,530
 Accounts receivable -- trade (net of
 allowance for doubtful accounts of
 $75,000 in 1992 and $5,000 in 1991) 109,433 76,665
 Accounts receivable -- other --- 43,750
 Inventory 11,910 14,641
 Prepaid expenses and other current assets 133,143 11,010
 Total current assets 1,361,086 178,596
 Equipment and other depreciable assets,
 net of depreciation 674,528 146,709
 Scanner technology, net of amortization 2,252,750 ---
 Chamber patents, net of amortization 61,901 35,786
 Total assets $4,350,265 $361,091
 Liabilities and Stockholders' Equity:
 Current liabilities:
 Capital lease obligations $9,142 ---
 Accounts payable 179,228 32,851
 Accrued expenses and other liabilities 89,818 7,250
 Notes payable -- stockholders 437,710 ---
 Notes payable -- other 30,967 7,947
 Total current liabilities 746,865 48,048
 Capital lease obligations 141,227 ---
 Total liabilities 888,092 48,048
 Stockholders' equity:
 Common stock $.001 par value, 50 million shares
 authorized, 22,243,000 and 14,900,000 issued
 at March 31, 1992 and 1991, respectively 22,243 14,900
 Additional paid-in capital 4,554,960 433,186
 Accumulated deficit (1,089,480) (135,043)
 Total 3,487,723 313,043
 Less: treasury stock, at cost, 200,000 shares (25,550) ---
 Total stockholders' equity 3,462,173 313,043
 Total liabilities and stockholders' equity 4,350,265 361,091
 TOPOX, INC.
 Statements of Operations
 Periods ended Quarter Year
 March 31 1992 1991 1992 1991
 (unaudited)
 Gross revenues $122,747 $84,617 $530,283 $175,729
 Cost of sales 13,025 3,933 24,147 17,341
 Selling, general and
 administrative 325,449 82,817 974,261 149,727
 Research and development 128,861 15,000 128,861 15,000
 Depreciation and amortization 247,803 17,603 273,367 17,603
 Other income --- 543 --- 1,091
 Other expenses 82,928 --- 84,084 ---
 Net income (loss) (675,319) (34,193) (954,437) (22,851)
 Loss per share:
 Primary and fully diluted (A) (A) ($.06) (A)
 (A) Less than $.01 per share
 /delval/
 -0- 7/30/92
 /CONTACT: George Stasen, COO/EVP of Topox, 800-38-TOPOX/
 (TPO) CO: Topox, Inc. ST: Pennsylvania IN: HEA SU: ERN


CC-MP -- PH007 -- 4982 07/30/92 10:00 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 30, 1992
Words:676
Previous Article:UP-TO-MINUTE OLYMPIC RESULTS ARE AT YOUR FINGERTIPS WITH THE NEW MCI CARD
Next Article:BED BATH & BEYOND REPORTS JULY 1992 SALES
Topics:


Related Articles
TOPOX ANNOUNCES COMPLETION OF RECENT PRIVATE PLACEMENT AND ACCEPTANCE TO LIST ON EMERGING COMPANY MARKETPLACE
U.S. ALCOHOL TESTING OF AMERICA INC. REPORTS REVENUE, LOSSES FOR THE FISCAL YEAR ENDED MARCH 31, 1992
BROCK EXPLORATION CONTINUES TO REPORT POSITIVE EARNINGS
SK TECHNOLOGIES REPORTS FISCAL YEAR END RESULTS
THE SOFTWARE TOOLWORKS REPORTS RESULTS FOR THE FISCAL YEAR AND QUARTER ENDED MARCH 31, 1992
TOPOX ANNOUNCES RESULTS FOR THE FIRST QUARTER ENDED JUNE 30, 1992
TOPOX ANNOUNCES THE FDA HAS RULED FAVORABLY ON ITS 510K APPLICATION
TOPOX AND APPLIED BIOSENSORS TO DEVELOP SKIN TISSUE MONITORING SYSTEM
TOPOX: AGREEMENT SIGNED TO MANUFACTURE INNOVATIVE MEDICAL DEVICES
U.S. ALCOHOL TESTING OF AMERICA INC. REPORTS REVENUES AND LOSSES FOR THE FISCAL YEAR ENDED MARCH 31, 1993

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters